Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Georgia O. F. Barros"'
Autor:
Kranthi K. Mandadi, Zivko L. Nikolov, Joe Molina, Carol Vargas-Bautista, Bassam B. Damaj, John L. Jifon, Georgia O. F. Barros, Steven G. White, Mona B. Damaj, Susan L. Woodard
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-16 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-16 (2020)
Plants represent a safe and cost-effective platform for producing high-value proteins with pharmaceutical properties; however, the ability to accumulate these in commercially viable quantities is challenging. Ideal crops to serve as biofactories woul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63ff8f6bf30c696271d187cd088c04e0
http://europepmc.org/articles/PMC7426418
http://europepmc.org/articles/PMC7426418
Publikováno v:
Molecular Pharming
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75da265371f6dca1492cde99982e588e
https://doi.org/10.1002/9781118801512.ch7
https://doi.org/10.1002/9781118801512.ch7
Autor:
Steven G. White, Lisa R. Wilken, T. E. Mirkov, Zivko L. Nikolov, Mona B. Damaj, M. A. T. Ballen, Georgia O. F. Barros, Susan L. Woodard
Publikováno v:
Bioprocess and Biosystems Engineering. 36:1407-1416
Increased industrial use of sugarcane (Saccharum spp. hybrid) for food and bioenergy has led to considerable improvements in its genetic transformation, which allowed the development of not only pest- and herbicide-resistant lines but also lines expr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::859a4cdbfb0911dc53f2111dbb4392f5
https://doi.org/10.1007/s00449-012-0878-y
https://doi.org/10.1007/s00449-012-0878-y
Publikováno v:
Biotechnology progress. 27(2)
Transgenic Lemna minor has been used successfully to produce several biotherapeutic proteins. For plant-produced mAbs specifically, the cost of protein A capture step is critical as the economic benefits of plant production systems could be erased if
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e7b53d99fe04ae850a4c37f9aefac01
https://pubmed.ncbi.nlm.nih.gov/21485031
https://pubmed.ncbi.nlm.nih.gov/21485031
Publikováno v:
2010 Pittsburgh, Pennsylvania, June 20 - June 23, 2010.
Transgenic plant systems have been proposed as alternative bioreactors to mammalian cell culture in the production of a variety of pharmaceutical proteins and other bioproducts. Phenolic compounds in transgenic plant extracts present obstacles in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd3d43b594a7f48eb023c0ae141209d2
https://doi.org/10.13031/2013.29671
https://doi.org/10.13031/2013.29671
Publikováno v:
Biotechnology and bioengineering. 104(3)
Several pharmaceutical protein products made in transgenic plant hosts are advancing through clinical trials. Plant hosts present a different set of impurities from which the proteins must be purified compared to other expression hosts such as mammal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d0e7af87d7b02ecdf9c2fb06c1c89e0
https://pubmed.ncbi.nlm.nih.gov/19575415
https://pubmed.ncbi.nlm.nih.gov/19575415
Publikováno v:
Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology. 150:S183-S184
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae27336f5c0ea31c8650c077be0ef4d0
https://doi.org/10.1016/j.cbpa.2008.04.494
https://doi.org/10.1016/j.cbpa.2008.04.494